Wilson Therapeutics
Wilson Therapeutics develops and commercializes novel therapies for the treatment of genetic and copper-mediated disorders.
Business Model:
Revenue: $6.4M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Wilson Therapeutics Information
Wilson Therapeutics was acquired by
Alexion Pharmaceuticals.
The acquisition happend on 2018-04-11.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Kungsgatan 3
City: Stockholm
State: stockholms län
Zip: 111 43
Country: SE
Financial Info
Stage:
post ipo equity
Raised Last:
$29M
Raised Total:$40M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Wilson Therapeutics develops and commercializes novel therapies for the treatment of genetic and copper-mediated disorders.
Contact Phone:
Contact Email:
Wilson Therapeutics went public on 5/12/2016 on the Nasdaq OMX Nordic
Listed Exchange:
Nasdaq OMX Nordic
IPO Date:
5/12/2016
Ticker Symbol:
WTX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2014 | Series B | 4 | $40M |
MVM Life Science Partners Neomed Management HealthCap Abingworth Abingworth MVM Life Science Partners MVM Life Science Partners Neomed Management HealthCap Abingworth Abingworth MVM Life Science Partners |
12/2017 | Post-IPO Equity | $28.9M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
